MedOncMD

To provide the information your oncologist is not telling you or doesn't have the time to!

  • Home
  • Blog
    • The essentials
    • Art of Oncology
    • Prevention and Healthy Lifestyle
    • Research Advances
    • Navigation Corner
    • Video Library
  • Meet and Greet
    • About Dr Thomas
    • About Dr Landau
  • Ask MedOncMD?
  • đź§  How I Create My Blog Posts

Varied Cancer Perspectives

Explore a comprehensive range of insights and information within our ‘Varied Cancer Perspectives’ category. From melanoma to breast cancer, colorectal cancer to sarcoma, and beyond, this diverse collection delves into the multifaceted world of oncology. Gain a nuanced understanding of different cancer types, treatments, and the latest advancements in research. Whether you’re seeking knowledge on pediatric oncology, uveal melanoma, or desmoid tumors, our curated content provides a holistic view, offering valuable perspectives to empower and inform those navigating the complexities of cancer care. Join us on a journey through varied perspectives, ensuring a well-rounded understanding of the ever-evolving landscape of cancer.

Brain Tumors: A Closer Look at CNS Malignancies Through the Lives of Dikembe Mutombo and Jimmy Carter

The world recently lost NBA legend Dikembe Mutombo to brain cancer, while former President Jimmy Carter continues to defy expectations. Despite being diagnosed with metastatic melanoma, including brain and liver metastasis he has just celebrated his 100th birthday. These two public figures have brought significant attention to CNS (Central Nervous System) malignancies, sparking curiosity about the different types of brain tumors, how …

Read On »

FDA Approves Inavolisib for Endocrine-Resistant Advanced Breast Cancer: A New Option for PIK3CA-Mutated Patients

On October 10, 2024, the FDA approved a new and promising treatment for patients with advanced breast cancer: inavolisib (Itovebi), in combination with palbociclib and fulvestrant. This new approval offers fresh hope for patients with endocrine-resistant, PIK3CA-mutated, hormone receptor (HR)-positive, and HER2-negative breast cancer, especially those whose disease has progressed after endocrine therapy. The approval also includes the FoundationOne Liquid CDx assay, a diagnostic test used to …

Read On »

New Hope for Limited-Stage Small-Cell Lung Cancer: Durvalumab Shows Promising Results After Chemoradiotherapy

Small-cell lung cancer (SCLC) is a notoriously aggressive form of lung cancer, making up about 15% of all lung cancer cases. While treatments have made strides in extensive-stage SCLC, limited-stage SCLC has seen few advancements in decades—until now. A new clinical trial published in the New England Journal of Medicine has revealed promising results with the use …

Read On »

A Promising New Treatment for Metastatic Breast Cancer: Exploring Bria-IMT™ and Its Impact

A Promising New Treatment for Metastatic Breast Cancer: Exploring Bria-IMT™ and Its Impact When battling metastatic breast cancer, finding effective treatment options can feel like an uphill battle, especially when cancer has spread to other areas, like the brain. But new hope is on the horizon. A groundbreaking therapy called Bria-IMT™ is showing promising results in clinical …

Read On »

Targeting Cancer at Its Core: Unlocking the Power of Biomarker-Driven Therapies in Breast Cancer Treatment

Breast Cancer Treatment October is Breast Cancer Awareness Month, a time dedicated to spreading knowledge, supporting research, and empowering patients and healthcare providers alike. Throughout the month, we’ll explore various critical aspects of breast cancer care. In this post, we focus on the current role of targeted therapies in treatment and encourage both patients and …

Read On »

Immunotherapy in Breast Cancer: A Modern Approach to Treatment

October is Breast Cancer Awareness Month, a time dedicated to spreading knowledge, supporting research, and empowering patients and healthcare providers alike. Throughout the month, we’ll explore various critical aspects of breast cancer care. In this post, we focus on the current role of immunotherapy in treatment and encourage both patients and providers to consider clinical …

Read On »

A Promising New Treatment for Chronic Myeloid Leukemia: What You Should Know About Asciminib

A recent New England Journal of Medicine study introduces asciminib, a new treatment for Chronic Myeloid Leukemia (CML) that shows improved effectiveness and fewer side effects compared to current therapies. This post will explain the study’s findings and what they mean for patients and caregivers, highlighting how asciminib could offer a better option for those newly diagnosed with …

Read On »

Advancing Breast Cancer Prevention: A Comprehensive Oncologist’s Perspective

October: Breast Cancer Awareness Month October is Breast Cancer Awareness Month, a time dedicated to raising awareness, supporting research, and encouraging early detection. In honor of this important cause, we’re highlighting crucial preventive measures and ways to reduce breast cancer risk. This article also connects to the ongoing efforts to support breast cancer research, with …

Read On »

Immunotherapy Post-Surgery Improves Survival in High-Risk Bladder Cancer

Sophia’s Story I’ll never forget the day I met Sophia. She sat in my clinic, a mother of two and a dedicated teacher, but her eyes were clouded with fear. When she first received the news that she had high-risk bladder cancer, she told me she felt like the ground had shifted beneath her feet. …

Read On »

Jimmy Carter and the Power of Immunotherapy: A Shift from Palliative to Curative Intent

When I meet new patients diagnosed with Stage IV metastatic melanoma, I often mention the name Jimmy Carter. It’s a name most people recognize, and his survival story is nothing short of remarkable—especially considering he will soon celebrate his 100th birthday. Like many of my patients, Carter was diagnosed with Stage IV melanoma, with metastatic …

Read On »

  • Previous
  • Page 1
  • …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • …
  • Page 13
  • Next

Recent Posts

  • When a Locum Assignment Ends Differently Than Expected
  • The mRNA moment in melanoma: a 5-year update—and a flashback to the COVID era
  • Emerging Data in Intratumoral Immunotherapy: Replimmune’s RP1 + Nivolumab in Non‑Melanoma Skin Cancers and Acral Melanoma
  • 12 Things I Learned in My First 6 Weeks at AdventHealth
  • 2025 Reflections and 2026 Aspirations: A Medical Oncologist’s Journey in Clinical Excellence, Innovation, and Intentional Living

Categories

  • Art of Oncology (97)
  • Current News (16)
  • Immunotherapy News (12)
  • Navigation Corner (6)
  • Prevention and Healthy Lifestyle (18)
  • Reflections (4)
  • Research Advances (120)
    • Clinical Trials (51)
    • Immunotherapy (33)
    • New Treatments and Therapies (44)
  • The essentials (41)
    • Radiology (4)
  • Travel Health (1)
  • Uncategorized (10)
  • Varied Cancer Perspectives (126)
    • Biliary tract cancer (3)
    • Bladder Cancer (3)
    • Breast Cancer (10)
    • Cervical Cancer (2)
    • CNS Cancers (1)
    • Colorectal cancer (15)
    • Esophageal Cancer (2)
    • Gastric cancer (6)
    • Hepatic Tumors (1)
    • Leiomyosarcoma (2)
    • Leukemia (3)
    • Lung Cancer (11)
    • Lymphoma (3)
    • Melanoma (34)
    • Multiple Myeloma (3)
    • Neuroendocrine cancer (2)
    • Ovarian Cancer (3)
    • Pancreatic Cancer (5)
    • Prostate Cancer (5)
    • Sarcoma (2)
    • Sickle Cell Disease (4)
    • Skin Cancer (9)
    • Thyroid cancer (1)
    • Urothelial Cancer (1)
  • Video (2)
  • Weekly Newsletter (6)

Get in touch!

  • Facebook
  • Instagram
  • TikTok
  • LinkedIn


Meet the authors

Dr. Sajeve Thomas
Dr Daniel Landau


Subscribe


  • Home
  • Blog
    • The essentials
    • Art of Oncology
    • Prevention and Healthy Lifestyle
    • Research Advances
    • Navigation Corner
    • Video Library
  • Meet and Greet
    • About Dr Thomas
    • About Dr Landau
  • Ask MedOncMD?
  • đź§  How I Create My Blog Posts
© 2026 MedOncMD. Minimal Theme by SPYR
✕
  • Home
  • Blog
    • The essentials
    • Art of Oncology
    • Prevention and Healthy Lifestyle
    • Research Advances
    • Navigation Corner
    • Video Library
  • Meet and Greet
    • About Dr Thomas
    • About Dr Landau
  • Ask MedOncMD?
  • đź§  How I Create My Blog Posts